Director Paul A. Calvo, Ph.D., moderated the panel “Navigating the Unique Challenges of Patenting and Protecting Personalized Medicine” at C5’s 21st Annual Life Sciences IP Summit on Thursday, September 28, 2023, in Munich, Germany. Speakers from the pharma, biotech and medical device industries provided practical insights on procuring and maintaining patents in the Unitary Patent era, as well as provided offensive and defensive patent litigation strategies for the new Unified Patent Court.

Panel Overview

While precision medicine is expanding and transforming treatment opportunities for patients, it comes with a number of intellectual property challenges that must be overcome to ensure that the inherent technologies can continue to evolve. This panel analyzed the host of IP hurdles faced by claimants of personalized medicine patents and strategies for overcoming them. Topics of discussion included:

  • Understanding the unique challenges of asserting IP of personalized medicine
  • Best practices for tackling IP hurdles of precision medicine, including subject matter eligibility, proving infringement and software licensing